Lynx Investment Advisory’s Medtronic MDT Stock Holding History

Lynx Investment Advisory’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-359	Closed	-$28.2K	–	507
2024 Q2	$28.2K	Buy	+359	New	+$29.4K	0.02%	303

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Lynx Investment Advisory's MDT Position: Q3 2024 in Review

Lynx Investment Advisory sold out of Medtronic (MDT) in Q3 2024, closing a stake of 359 shares — an estimated $28.2K sold.

Lynx Investment Advisory first reported a position in MDT in Q2 2024 and held it in 1 quarter. The position peaked at $28.2K in Q2 2024. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

Lynx Investment Advisory reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
Lynx Investment Advisory sold 359 Medtronic shares in Q3 2024, an estimated $28.2K.
Lynx Investment Advisory first reported a position in Medtronic in Q2 2024 and held it in 1 quarter.
Lynx Investment Advisory's Medtronic position peaked at $28.2K in Q2 2024.
2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Lynx Investment Advisory's 13F filing for Q3 2024, filed 4 Nov 2024.